Press Releases

Date Title and Summary Additional Formats
Toggle Summary Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial; Potential Best-in-Class Non-Hormonal Treatment for Vasomotor Symptoms
Potential Best-in-Class Non-Hormonal Treatment for Vasomotor Symptoms
View HTML
Toggle Summary Concert Pharmaceuticals Named One of the "Fierce 15" Biotech Companies of 2008
June 24, 2008 Lexington, MA – Concert Pharmaceuticals, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotechnology companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on a
View HTML
Toggle Summary Concert Pharmaceuticals Raises $37 Million in Series C Financing
Broad Syndicate of New and Existing Investors
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference
Concert Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference LEXINGTON, MASS. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today that it will be presenting at
View HTML
Toggle Summary Concert Pharmaceuticals Names W. James O’Shea and Daniel Grau to Product Advisory Board
Concert Pharmaceuticals Names W. James O’Shea and Daniel Grau to Product Advisory Board LEXINGTON, Mass. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today the addition of two new members to
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference
Concert Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference LEXINGTON, MASS. — Concert Pharmaceuticals, Inc.™, the first company dedicated to creating safer, more effective medicines using precision deuterium chemistry, announced today that it will be presenting at the 26th
View HTML